Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,775.00
-60.00 (-1.56%)
Oct 2, 2026, 3:30 PM JST
Kaken Pharmaceutical Market Cap
Kaken Pharmaceutical has a market cap or net worth of 142.95 billion as of October 2, 2026. Its market cap has increased by 4.29% in one year.
Market Cap
142.95B
Enterprise Value
88.66B
Revenue
88.16B
Ranking
n/a
PE Ratio
13.86
Stock Price
3,775.00
ChartMarket Cap Chart
Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 142.95B, an increase of 20.76%. That is a compound annual growth rate of 0.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 142.95B | -5.98% |
| Dec 30, 2025 | 152.04B | -11.05% |
| Dec 30, 2024 | 170.93B | 34.53% |
| Dec 29, 2023 | 127.05B | -12.84% |
| Dec 30, 2022 | 145.77B | -8.45% |
| Dec 30, 2021 | 159.22B | 3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tsumura & Co. | 276.04B |
| Nippon Shinyaku | 227.68B |
| Sawai Group Holdings | 183.82B |
| Towa Pharmaceutical | 172.05B |
| Kissei Pharmaceutical | 153.09B |
| Mochida Pharmaceutical | 108.96B |
| Zeria Pharmaceutical | 83.66B |
| KYORIN Pharmaceutical | 61.18B |